Esperion Therapeutics Inc (ESPR)
1.85
-0.02
(-1.06%)
USD |
NASDAQ |
Apr 19, 09:48
Esperion Therapeutics Cash and Short Term Investments (Quarterly): 82.25M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.25M |
| September 30, 2023 | 114.83M |
| June 30, 2023 | 138.47M |
| March 31, 2023 | 162.34M |
| December 31, 2022 | 166.86M |
| September 30, 2022 | 189.34M |
| June 30, 2022 | 185.84M |
| March 31, 2022 | 218.50M |
| December 31, 2021 | 259.33M |
| September 30, 2021 | 103.67M |
| June 30, 2021 | 219.19M |
| March 31, 2021 | 217.94M |
| December 31, 2020 | 304.96M |
| September 30, 2020 | 215.75M |
| June 30, 2020 | 300.74M |
| March 31, 2020 | 157.32M |
| December 31, 2019 | 200.78M |
| September 30, 2019 | 243.86M |
| June 30, 2019 | 301.23M |
| March 31, 2019 | 228.53M |
| December 31, 2018 | 136.02M |
| September 30, 2018 | 159.22M |
| June 30, 2018 | 180.17M |
| Date | Value |
|---|---|
| March 31, 2018 | 197.22M |
| December 31, 2017 | 200.20M |
| September 30, 2017 | 203.37M |
| June 30, 2017 | 167.41M |
| March 31, 2017 | 181.88M |
| December 31, 2016 | 211.58M |
| September 30, 2016 | 210.10M |
| June 30, 2016 | 207.18M |
| March 31, 2016 | 194.47M |
| December 31, 2015 | 212.26M |
| September 30, 2015 | 215.60M |
| June 30, 2015 | 224.78M |
| March 31, 2015 | 278.11M |
| December 31, 2014 | 105.84M |
| September 30, 2014 | 52.96M |
| June 30, 2014 | 59.72M |
| March 31, 2014 | 56.70M |
| December 31, 2013 | 60.06M |
| September 30, 2013 | 71.90M |
| June 30, 2013 | 16.63M |
| March 31, 2013 | 20.89M |
| December 31, 2012 | 6.512M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
82.25M
Minimum
Dec 2023
304.96M
Maximum
Dec 2020
199.12M
Average
200.78M
Median
Dec 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| United Therapeutics Corp | 2.994B |
| Masimo Corp | 163.00M |
| Heron Therapeutics Inc | 80.41M |
| Aldeyra Therapeutics Inc | 142.82M |
| Aravive Inc (DELISTED) | 8.535M |